Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D002749:Chlorprothixene / Q000494:pharmacology; D003192:Compulsive Behavior / Q000187:drug effects; D003907:Dexamethasone / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004336:Drug Antagonism; D004347:Drug Interactions; D004357:Drug Synergism; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D008094:Lithium / Q000494:pharmacology; D008297:Male; D008653:Mesoridazine / Q000494:pharmacology; D008728:Methotrimeprazine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D011346:Prochlorperazine / Q000494:pharmacology; D011395:Promazine / Q000494:pharmacology; D011398:Promethazine / Q000494:pharmacology; D011803:Quinine / Q000494:pharmacology; D051381:Rats; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014273:Triflupromazine / Q000494:pharmacology; D014859:Warfarin / Q000494:pharmacology
D014149:Tranquilizing Agents; D014859:Warfarin; D008653:Mesoridazine; D003907:Dexamethasone; D008094:Lithium; D008728:Methotrimeprazine; D002749:Chlorprothixene; D011803:Quinine; D011398:Promethazine; D006220:Haloperidol; D011395:Promazine; D014273:Triflupromazine; D003913:Dextroamphetamine; D002746:Chlorpromazine; D011346:Prochlorperazine